lixte - Robuta Search

https://lixte.com/ LIXTE: Advancing novel oncology treatments and cancer therapies May 15, 2026 - Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) is a clinical-stage pharmaceutical company developing a new class of oncology treatments and cancer therapies... lixte advancing novel oncology treatments https://investingnews.com/daily/life-science-investing/pharmaceutical-investing/lixte-biotechnology-enrolls-first-patients-in-lb-100-study/ Lixte Biotechnology Enrolls First Patients in LB-100 Study | INN Jan 2, 2026 - Lixte Biotechnology (OTCQB:LIXT) has announced that the National Cancer Institute (NCI) has enrolled the first two out of eight patients testing its lead... lb 100 lixte biotechnology first patients https://www.macrotrends.net/stocks/charts/LIXT/lixte-biotechnology-holdings/net-income Lixte Biotechnology Holdings Net Income 2017-2025 | LIXT | MacroTrends Lixte Biotechnology Holdings net income from 2017 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and... net income lixte biotechnology holdings 2017 https://www.macrotrends.net/stocks/charts/LIXT/lixte-biotechnology-holdings/gross-margin Lixte Biotechnology Holdings Gross Margin 2017-2025 | LIXT | MacroTrends Current and historical gross margin for Lixte Biotechnology Holdings (LIXT) over the last 10 years. The current gross profit margin for Lixte Biotechnology... gross margin lixte biotechnology holdings 2017 https://stockanalysis.com/stocks/lixt/employees/ Lixte Biotechnology Holdings (LIXT) Number of Employees Current and historical number of employees for Lixte Biotechnology Holdings (LIXT) with related statistics, a chart and a data table. lixte biotechnology holdings number employees https://www.newsfilecorp.com/release/265118/247-Market-News-LIXTE-Holds-the-Worlds-Only-ClinicalStage-PP2A-Inhibitor 24/7 Market News: LIXTE Holds the World's Only Clinical-Stage PP2A Inhibitor Denver, Colorado--(Newsfile Corp. - September 5, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of... https://www.biospace.com/lixte-netherlands-cancer-institute-and-oncode-institute-to-expand-collaboration LIXTE, Netherlands Cancer Institute, and Oncode Institute to Expand Collaboration - BioSpace Oct 17, 2023 - LIXTE Biotechnology Holdings, Inc. announced that it has signed an agreement to expand its collaboration with the Netherlands Cancer Institute and Oncode... netherlands cancer institute lixte expand collaboration https://investingnews.com/daily/life-science-investing/biotech-investing/lixte-biotechnology-clinical-trial-agreement/ Lixte Biotechnology Announces Clinical Trial Agreement | INN Jan 4, 2026 - On Tuesday (August 21), Lixte Biotechnology (OTCQB:LIXT) announced a new clinical trial agreement with the Florida-based Moffitt Cancer Center. The clinical... clinical trial lixte biotechnology announces agreement https://stockanalysis.com/stocks/lixt/financials/ratios/ Lixte Biotechnology Holdings (LIXT) Financial Ratios Financial ratios for Lixte Biotechnology Holdings (LIXT). Includes annual, quarterly and trailing numbers with history and charts. lixte biotechnology holdings financial ratios https://www.nasdaq.com/market-activity/stocks/lixt/dividend-history Lixte Biotechnology Holdings, Inc. Common Stock (LIXT) Dividend History | Nasdaq Stay up-to-date on Lixte Biotechnology Holdings, Inc. Common Stock (LIXT) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule. common stock dividend history lixte biotechnology holdings